These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6979308

  • 1. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F, Saino Y, Koshi T, Hattori Y, Nakayama M, Iwasaki A, Mori T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [Abstract] [Full Text] [Related]

  • 2. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K, Harada S, Shinagawa S, Imada A, Kuno M.
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [Abstract] [Full Text] [Related]

  • 3. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M, Nakazawa H, Hashimoto T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [Abstract] [Full Text] [Related]

  • 4. PS-6 and PS-7, new beta-lactam antibiotics. In vitro and in vivo evaluation.
    Sakamoto M, Shibamoto N, Iguchi H, Okamura K, Hori S, Fukagawa Y, Ishikura T, Lein J.
    J Antibiot (Tokyo); 1980 Oct; 33(10):1138-45. PubMed ID: 7451364
    [Abstract] [Full Text] [Related]

  • 5. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases.
    Okonogi K, Nozaki Y, Imada A, Kuno M.
    J Antibiot (Tokyo); 1981 Feb; 34(2):212-7. PubMed ID: 6975270
    [Abstract] [Full Text] [Related]

  • 6. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 7. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D, Muller-Serieys C, Picard B, Bergogne-Berezin E, Lambert-Zechovsky N.
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [Abstract] [Full Text] [Related]

  • 8. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F, Keeble J, Williams JD.
    Rev Infect Dis; 1986 Nov; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 Nov; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 10. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T, Tsukamoto K.
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [Abstract] [Full Text] [Related]

  • 11. Comparative inhibition beta-lactamases by novel beta-lactam compounds.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):171-6. PubMed ID: 311616
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K, Griffin DR, Page JW, Upshon PA.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
    [Abstract] [Full Text] [Related]

  • 13. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
    Reading C, Cole M.
    Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.
    Gutmann L, Kitzis MD, Yamabe S, Acar JF.
    Antimicrob Agents Chemother; 1986 May; 29(5):955-7. PubMed ID: 3015011
    [Abstract] [Full Text] [Related]

  • 15. PS-5, a new beta-lactam antibiotic. II. Antimicrobial activity.
    Sakamoto M, Iguchi H, Okamura K, Hori S, Fukagawa Y, Ishikura T, Lein J.
    J Antibiot (Tokyo); 1979 Apr; 32(4):272-9. PubMed ID: 38238
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC, Jones RN.
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
    Neu HC, Novelli A, Chin NX.
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493
    [Abstract] [Full Text] [Related]

  • 18. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K, Sakamoto M, Fukagawa Y, Ishikura T, Lein J.
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T, Mitsuhashi S.
    Arzneimittelforschung; 1977 Apr; 27(1):89-93. PubMed ID: 576821
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.